CD274 and liver cancer: IFN-γ exposure in the tumor microenvironment enhances liver cancer stem cell stemness and sorafenib resistance by promoting mitochondrial PD-L1-mediated glycolytic reprogramming and ferroptosis inhibition via the Drp1-GPX4 pathway.